CRVO vs IDXX · $28.8M cap vs P/E 40, rev $2.36B
CervoMed Inc. (CRVO) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
CervoMed Inc. (CRVO) is a biotechnology company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported CRVO revenue for 2026-06-30 was $0. Net income was -$14.5M. CRVO currently screens at market cap $28.8M.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
CRVO currently screens at market cap $28.8M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the CRVO and IDXX stock pages for the full models.
Not investment advice.